Your browser doesn't support javascript.
loading
Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.
Leclair, Valérie; Landon-Cardinal, Océane; Aggarwal, Rohit; Bansback, Nick; Campbell, Craig; Feldman, Brian M; Jarry, Martin; McNamara, Suzan; White, Barbara; Hudson, Marie.
Afiliación
  • Leclair V; V. Leclair, MD, Department of Medicine, McGill University, and Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada; valerie.leclair@mcgill.ca.
  • Landon-Cardinal O; O. Landon-Cardinal, MD, Department of Medicine, Université de Montréal, and Division of Rheumatology and Research Center, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Aggarwal R; R. Aggarwal, MD, MSc, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Bansback N; N. Bansback, PhD, University of British Columbia and Arthritis Research Canada, Vancouver, British Columbia, Canada.
  • Campbell C; C. Campbell, MD, Department of Pediatrics, London Children's Hospital, University of Western Ontario, London, Ontario, Canada.
  • Feldman BM; B.M. Feldman, MD, MSc, Faculty of Medicine and IHPME Dalla Lana School of Public Health, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Jarry M; M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.
  • McNamara S; M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.
  • White B; M. Jarry, Patient Advocate, S. McNamara, PhD, B. White, MD, Corbus Pharmaceutical Holdings Inc., Norwood, Massachusetts, USA.
J Rheumatol ; 47(10): 1584-1586, 2020 10 01.
Article en En | MEDLINE | ID: mdl-32541080
ABSTRACT
The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polimiositis / Miositis por Cuerpos de Inclusión / Dermatomiositis / Miositis Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Rheumatol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polimiositis / Miositis por Cuerpos de Inclusión / Dermatomiositis / Miositis Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Rheumatol Año: 2020 Tipo del documento: Article